Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alto Neuroscience (ANRO) Change in Account Payables (2023 - 2026)

Alto Neuroscience has reported Change in Account Payables over the past 4 years, most recently at $1.5 million for Q1 2026.

  • Quarterly results put Change in Account Payables at $1.5 million for Q1 2026, up 660.15% from a year ago — trailing twelve months through Mar 2026 was $2.0 million (up 327.24% YoY), and the annual figure for FY2025 was $221000.0, down 57.17%.
  • Change in Account Payables reached $1.5 million in Q1 2026 per ANRO's latest filing, up from -$297000.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $1.5 million in Q1 2026 and bottomed at -$781000.0 in Q4 2023.
  • Median Change in Account Payables over the past 4 years was -$251000.0 (2024), compared with a mean of $122692.3.
  • The largest annual shift saw Change in Account Payables plummeted 123.75% in 2025 before it skyrocketed 660.15% in 2026.
  • Over 4 years, Change in Account Payables stood at -$781000.0 in 2023, then increased by 2.43% to -$762000.0 in 2024, then soared by 61.02% to -$297000.0 in 2025, then skyrocketed by 601.68% to $1.5 million in 2026.
  • Business Quant data shows Change in Account Payables for ANRO at $1.5 million in Q1 2026, -$297000.0 in Q4 2025, and $461000.0 in Q3 2025.